Detalles de la búsqueda
1.
The UDP-Glycosyltransferase (UGT) Superfamily: New Members, New Functions, and Novel Paradigms.
Physiol Rev;
99(2): 1153-1222, 2019 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30724669
2.
Interfacial Assembly of Bacterial Microcompartment Shell Proteins in Aqueous Multiphase Systems.
Small;
20(15): e2308390, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38037673
3.
A lack of association between BMI and chemoimmunotherapy efficacy in advanced non-small cell lung cancer: Secondary analysis of the IMpower150 and IMpower130 clinical trials.
BMC Cancer;
24(1): 379, 2024 Mar 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38528478
4.
Proteomic profiling of paired human liver homogenate and tissue derived extracellular vesicles.
Proteomics;
: e2300025, 2023 Nov 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38037300
5.
A 10-year update to the principles for clinical trial data sharing by pharmaceutical companies: perspectives based on a decade of literature and policies.
BMC Med;
21(1): 400, 2023 10 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-37872545
6.
Developing rights-based standards for children having tests, treatments, examinations and interventions: using a collaborative, multi-phased, multi-method and multi-stakeholder approach to build consensus.
Eur J Pediatr;
182(10): 4707-4721, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37566281
7.
Circulating cell-specific extracellular vesicles as biomarkers for the diagnosis and monitoring of chronic liver diseases.
Cell Mol Life Sci;
79(5): 232, 2022 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35397694
8.
Time to change the reference ranges of children's physiological observations in emergency care? A prospective study.
J Paediatr Child Health;
59(3): 480-486, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36645173
9.
Efficacy of first-line atezolizumab combination therapy in patients with non-small cell lung cancer receiving proton pump inhibitors: post hoc analysis of IMpower150.
Br J Cancer;
126(1): 42-47, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34711947
10.
A Physiologically Based Pharmacokinetic Model to Predict the Impact of Metabolic Changes Associated with Metabolic Associated Fatty Liver Disease on Drug Exposure.
Int J Mol Sci;
23(19)2022 Oct 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36233052
11.
Patient-Reported Outcomes Predict Progression-Free Survival of Patients with Advanced Breast Cancer Treated with Abemaciclib.
Oncologist;
26(7): 562-568, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33914991
12.
Role of Extracellular Vesicle-Derived Biomarkers in Drug Metabolism and Disposition.
Drug Metab Dispos;
49(11): 961-971, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34353847
13.
Formation and properties of liposome-stabilized all-aqueous emulsions based on PEG/dextran, PEG/Ficoll, and PEG/sulfate aqueous biphasic systems.
Soft Matter;
17(13): 3688-3699, 2021 Apr 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33683232
14.
Patient-reported outcomes as a prognostic marker of survival in patients with advanced nonsmall cell lung cancer treated with immunotherapy.
Int J Cancer;
147(11): 3085-3089, 2020 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32492185
15.
Profiling of Drug-Metabolizing Enzymes and Transporters in Human Tissue Biopsy Samples: A Review of the Literature.
J Pharmacol Exp Ther;
372(3): 308-319, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31879375
16.
Induction of Human Intestinal and Hepatic Organic Anion Transporting Polypeptides: Where Is the Evidence for Its Relevance in Drug-Drug Interactions?
Drug Metab Dispos;
48(3): 205-216, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31879282
17.
Risk factors for severe rash with use of vemurafenib alone or in combination with cobimetinib for advanced melanoma: pooled analysis of clinical trials.
BMC Cancer;
20(1): 157, 2020 Feb 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-32103736
18.
Multiorgan Immune-Related Adverse Events During Treatment With Atezolizumab.
J Natl Compr Canc Netw;
18(9): 1191-1199, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32886899
19.
Effect of early adverse events resulting in sorafenib dose adjustments on survival outcomes of advanced hepatocellular carcinoma patients.
Int J Clin Oncol;
25(9): 1672-1677, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32417993
20.
Effect of early adverse events resulting in ado-trastuzumab emtansine dose adjustments on survival outcomes of HER2+ advanced breast cancer patients.
Breast Cancer Res Treat;
178(2): 473-477, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31399933